H.R. 4404 · 116th Congress
Depression Side Effect Labeling Awareness Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
RushSponsor7 cosponsors · 7 D
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.
What it does: CRS summary · Introduced in House · Sep 19, 2019
Depression Side Effect Labeling Awareness Act of 2019
This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Depression Side Effect Labeling Awareness Act of 2019
Latest action (Sep 20, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Sep 19, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.